Swiss team uses artificial lung in new Covid-19 research
Doctors still don't fully understand why some Covid-19 patients develop blood clots in the lungs. EPFL research hopes to find out.
Keystone / Laurent Gillieron
Scientists at the Federal Technology Institute Lausanne (EPFL) have developed a simplified model of a human lung that lets them investigate how Covid-19 causes blood clots.
This content was published on
2 minutes
EPFL/jc
COVID-19 sometimes causes blood clots, but doctors are still not sure why, an EPFL press releaseExternal link explains. Around 10% of hospitalized patients develop this complication, according to a recent studyExternal link. In the most severe cases, the blood clots can lead to a stroke.
“To get more insight into this phenomenon, EPFL scientists have developed a microfluidic chip that models the human lung and replicates part of its structure to study COVID-19 infections,” says EPFL. “The chip can hold lung epithelial cells, blood-vessel cells and immune-system cells, and lets scientists directly watch how SARS-CoV-2 attacks human cells and triggers the formation of blood clots.”
Two mechanisms are suspected to be at work, according to EPFL. One is an excess production of cytokines, causing an overreaction of the immune system which can damage blood vessels, cause blood clots to form, and are potentially fatal. The other possible mechanism is damage to the interior lining of blood vessels – or the endothelium – in the lungs.
So which mechanism is the likely culprit? “To find out, doctors need to be able to watch how the infection progresses in the lungs hour by hour,” says the press release. “That’s nearly impossible in living patients and not very feasible in lab cultures either, since cultures usually contain just one kind of cell and don’t provide a realistic enough representation of the entire lung system.”
“With our lung-on-a-chip system, we found that the virus may be causing blood clots by attacking the endothelium directly,” says Vivek Thacker, who is leading the research. “However, that doesn’t mean that cytokines don’t play a role too and make things worse.”
The team will next use their lung-on-a-chip with actual blood samples so that they can observe clot formation directly.
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
High-net-worth individuals prioritise well-being over material possessions
This content was published on
The priorities of wealthy private individuals have shifted against the backdrop of ongoing geopolitical tensions and trade disputes. While spending on luxury goods is declining, demand for travel and experiences is unabated.
Swiss researchers sequence genome of 1918 Spanish flu virus
This content was published on
Researchers from the Universities of Basel and Zurich (UZH) have sequenced the genome of the Spanish flu virus, thanks to a sample taken from an 18-year-old Swiss boy who died in the city on the Limmat in 1918, when the pandemic spread around the world.
Swiss martyr beatified in Barcelona by Catholic Church
This content was published on
François-Benjamin May (1870-1909), a member of the Marist Brothers congregation, has been recognised as a 'blessed' by the Catholic Church.
Prevention and tech could help save billions on Swiss healthcare costs, says Deloitte
This content was published on
By focusing on prevention and technology, it would be possible to reduce Switzerland's healthcare bill by CHF30 billion a year by 2040, according to Deloitte Switzerland.
Environment director warns of increasing climate-related risks in Switzerland
This content was published on
The director of the Swiss Federal Office for the Environment (FOEN) has warned of increasing climate-related risks in Switzerland in an interview with SonntagsBlick on Sunday.
Gotthard traffic queue hits 11km at start of holiday season
This content was published on
The start of the summer holidays saw a long traffic jam in front of the Gotthard tunnel on Saturday. Traffic jams between Erstfeld and Göschenen in canton Uri were up to 11 kilometres long early in the morning.
Discovery could help stop Covid-19, say Swiss scientists
This content was published on
A protein produced by the human immune system can strongly inhibit corona viruses, including SARS-CoV2, the pathogen causing Covid-19.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.